Social and Psychological Impacts of SARS-Cov-2 Pandemic Period in the Obese Population.

The population suffering from obesity is particularly at risk during this pandemic period. The Nouvelle Aquitaine region is not spared, since according to the regional epidemiological report of 7 May 2020, carried out by Santé Publique France, 39.2% of cases admitted to the intensive care unit in Nouvelle Aquitaine and presenting risk factors are overweight or obese.

Other risk factors, such as social-environmental factors, must be taken into consideration. Socio-demographic surveys in this area highlight the socio-economic and territorial inequalities that interfere with obesity issues. Similarly, the issues of stigmatisation and isolation seem to be at the heart of the question of how to deal with these people.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obesity Body Weight COVID-19 Coronaviridae Infections Coronavirus Infections Covid19 Infections Lung Diseases Nidovirales Infections Nutrition Disorders Nutritional and Metabolic Diseases Overnutrition Overweight Pathological Conditions, Signs and Symptoms Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

CHU de Limoges, Limoges, France

About this study

This is a prospective multicentre study. Participating patients will be recruited from the Specialised Obesity Centres (CHU and SSR, as well as patient associations) to fill in a questionnaire and take part in an interview (a varied panel representative of the target population in terms of place of residence, socio-professional category, sex and age).

The medical and paramedical staff involved in the partner CSOs and the patients' resources (identified by the patients' associations) will also be asked to participate in a semi-directive interview.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients 18 years of age.
Be registered in an active file of the 3 partner CSOs.

Exclusion criteria

Patients under 18 years of age.
Patients under protective measures or deprived of liberty:

pregnant or breastfeeding woman,
under guardianship,
under guardianship,
safeguard of justice,
incarcerated.

Treatment and study plan

Questionnaire

Other

Questionnaire with 4 axes:

sociological, reflexive medical, prospective medical, transversal

interview

Other

Interview concerning health pathways, experience of confinement, consequences of confinement on health, representations of obesity.

Primary outcomes

Analysed social and psychological impacts of containment

Time frame: 9 months after inclusion day

Thanks to sociology questionnaire based on the experience and paths of individuals (not a score).

The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.
Consequences of social distancing during the containment

Time frame: 9 months after inclusion day

Thanks to sociology questionnaire based on the experience and paths of individuals(not a score).

The treatments carried out will be limited to cross sorting and flat sorting, factorial analyzes and -previously- the chi-square analysis.

Sponsors and collaborators

Lead sponsor

University Hospital, Bordeaux

Other

Collaborators

Région Nouvelle Aquitaine

Registry information

Acronym: OBIMPACOV

Important dates

Study start: 2022
Primary completion: 2023
Study completion: 2023
First posted: Jun 2, 2021
Registry last updated: Jan 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed